PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.520.06 (-1.08%)
5.46 - 5.56
4.95 - 8.28
1.7K / 2.4K (Avg.)
-276.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.85%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-16.31%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-89.49%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-89.49%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-76.26%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-76.43%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-76.43%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.28%
Slight or no buybacks while VALMT.HE is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.28%
Slight or no buyback while VALMT.HE is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
391.03%
OCF growth above 1.5x VALMT.HE's 254.05%. David Dodd would confirm a clear edge in underlying cash generation.
191.44%
FCF growth 1.25-1.5x VALMT.HE's 140.54%. Bruce Berkowitz would see if capex decisions or cost controls create a cash flow advantage.
-3.24%
Negative 10Y revenue/share CAGR while VALMT.HE stands at 70.39%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
2.12%
5Y revenue/share CAGR under 50% of VALMT.HE's 35.88%. Michael Burry would suspect a significant competitive gap or product weakness.
3.58%
3Y revenue/share CAGR under 50% of VALMT.HE's 26.78%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
793.33%
10Y OCF/share CAGR above 1.5x VALMT.HE's 275.62%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
43.94%
Positive OCF/share growth while VALMT.HE is negative. John Neff might see a comparative advantage in operational cash viability.
4.91%
Positive 3Y OCF/share CAGR while VALMT.HE is negative. John Neff might see a big short-term edge in operational efficiency.
-33.77%
Negative 10Y net income/share CAGR while VALMT.HE is at 553.38%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-91.72%
Negative 5Y net income/share CAGR while VALMT.HE is 97.23%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-89.81%
Negative 3Y CAGR while VALMT.HE is 22.89%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
129.33%
10Y equity/share CAGR in line with VALMT.HE's 133.85%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
48.29%
Below 50% of VALMT.HE's 128.66%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
44.74%
Below 50% of VALMT.HE's 98.55%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-11.53%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-13.82%
Inventory is declining while VALMT.HE stands at 2.92%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-3.77%
Negative asset growth while VALMT.HE invests at 1.06%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-2.31%
We have a declining book value while VALMT.HE shows 4.27%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-2.03%
We’re deleveraging while VALMT.HE stands at 7.11%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-6.32%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.